VCEL
VCEL
NASDAQ · Biotechnology

Vericel Corp

$32.45
+1.04 (+3.31%)
As of Mar 23, 10:02 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +34.4% upside
Low Target $27.22
Average Target $43.60
High Target $49.94
Current Price $32.45
Current
$32.45
Target
$43.60
$27.22 $43.60 avg $49.94
Scenario Analysis
Bear Case
$27.22
-16.1%
Low target
Base Case
$43.60
+34.4%
Avg target
Bull Case
$49.94
+53.9%
High target
Risk/Reward
3.3x
Highly favorable
Price in Context
52-Week High
$51.93
-37.5% from high
52-Week Low
$29.24
+11.0% from low
Target vs 52W High
$43.60
-16.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%